GlassScriptPhysician profile
Dorothy D White
NPI 1710148853
$3,011.28
in general payments reported to CMS, 2019-2025
31 companies · $508 in 2025
The $508 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $502 · 2020: $65.35 · 2021: $44.04 · 2022: $1,047 · 2023: $578 · 2024: $268 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,334 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,334.04 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $780.00 | 2022 | |
| Astellas Pharma US INC | $318.41 | 2019-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $289.59 | 2019-2025 | Aptima, Acessa Provu System, Thinprep 2000 Processor |
| Sumitomo Pharma America, INC. | $219.54 | 2023-2025 | Myfembree |
| Abbvie INC. | $167.43 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Bayer Healthcare Pharmaceuticals INC. | $153.82 | 2019-2025 | |
| Ethicon US, LLC | $100.08 | 2023-2025 | Stratafix, Vistaseal, Surgicel Nu-Knit |
| Lupin INC. | $88.88 | 2019 | |
| Roche Diagnostics Corporation | $77.47 | 2019-2022 | |
| Pfizer INC. | $75.50 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $73.43 | 2022-2023 | |
| Dilon Technologies, INC. | $69.43 | 2023 | Hemoblast Bellows |
| Organon LLC | $69.35 | 2023-2025 | Nexplanon |
| Amgen INC. | $64.56 | 2024-2025 | Evenity, Prolia |
| Agile Therapeutics, INC. | $45.81 | 2022-2023 | Twirla |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $44.92 | 2019-2022 | |
| Mallinckrodt Enterprises LLC | $39.65 | 2019 | |
| Millicent US INC | $39.46 | 2024-2025 | Intrarosa, Femring |
| Duchesnay USA Incorporated | $37.58 | 2019 | |
| Exeltis, USA INC. | $31.16 | 2024-2025 | Slynd |
| Cgg Medical INC | $30.88 | 2025 | |
| Myovant Sciences INC. | $28.70 | 2022 | |
| Avion Pharmaceuticals | $25.31 | 2019-2020 | |
| Daiichi Sankyo INC. | $23.51 | 2019 | |
| Organogenesis INC. | $19.49 | 2023 | Puraply |
| Merck Sharp & Dohme LLC | $18.74 | 2019 | |
| Solventum Corporation | $18.20 | 2025 | Prevena |
| Exact Sciences Corporation | $17.12 | 2025 | The Cologuard Plus Collection Kit |
| Medicem INC. | $16.49 | 2022 | |
| Sage Therapeutics, LLC | $14.93 | 2019 | |
| Allergan, INC. | $11.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dorothy White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.